About Central Venous Catheters (CVCs)
Intravenous access catheters are used to deliver nutrients, fluids, and drugs such as antibiotics, analgesics, and antipyretics, when patient’s body is unable to take in food and nutrition on by own. It is also used for blood transfusion and correction of electrolyte imbalance in patients. These devices use intravenous route of administration that allows rapid delivery of medication and fluids.
Technavio’s analysts forecast the global central venous catheters (CVCs) market to grow at a CAGR of 3.94% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global central venous catheters (CVCs) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of CVCs.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Central Venous Catheters (CVCs) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Teleflex
• B. Braun Melsungen
• C. R. Bard
• Vygon
• Cook
• Edwards Lifesciences
Other prominent vendors
• Amecath
• AngioDynamics
• BACTIGUARD
• BD
• Biosensors International
• Boston Scientific
• CONMED
• Guangdong Baihe Medical Technology
• Intra special catheters
• isomed
• Kimal
• lepumedical
• Medical Components
• PRODIMED
• SCW MEDICATH
• SILMAG
• Smiths Medical
• Terumo
• TROGE MEDICAL
• TUOREN Medical
• VOGT MEDICAL
• ZOLL Medical
Market driver
• High prevalence of chronic disorders
• For a full, detailed list, view our report
Market challenge
• Mechanical complications
• For a full, detailed list, view our report
Market trend
• Rising popularity for antimicrobial CVCs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
• CVCs
PART 05: MARKET LANDSCAPE
• Market overview
• Five forces analysis
PART 06: MARKET SEGMENTATION BY MATERIAL
PART 07: MARKET SEGMENTATION BY PROPERTY
• Comparison by property
• Global non-antimicrobial CVCs market
• Global antimicrobial CVCs market
• Market opportunity by property
PART 08: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
PART 09: MARKET SEGMENTATION BY DESIGN
PART 10: MARKET SEGMENTATION BY END-USER
• Hospitals
• ASCs
• Others
PART 11: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – market size & forecast
• EMEA – market size & forecast
• APAC – market size & forecast
• Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 14: MARKET TRENDS
• Rising popularity for antimicrobial CVCs
• Technological advances in CVC
• Growing preference for pressure injectable CVC
PART 15: VENDOR LANDSCAPE
PART 16: VENDOR ANALYSIS
• Vendors overview
• Teleflex
• B. Braun Melsungen
• C. R. Bard
• Vygon
• Cook
• Edwards Lifesciences
• Other prominent vendors
PART 17: APPENDIX6
• List of abbreviations
List of Exhibits
Exhibit 01: Indications of usage of intravenous access catheters
Exhibit 02: Types of CVCs
Exhibit 03: Global CVCs market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Materials used in CVCs
Exhibit 06: Comparison of materials used in manufacturing CVCs
Exhibit 07: Segmentation of global CVCs market by property
Exhibit 08: Global CVCs market analysis by property 2016-2021 ($ millions)
Exhibit 09: Global CVCs market 2016 and 2021 ($ millions)
Exhibit 10: Global CVC market: Property analysis 2016-2021 (%)
Exhibit 11: Global CVCs market segmentation by property type 2016-2021 ($ millions)
Exhibit 12: Property – market size & forecast
Exhibit 13: Comparison by property
Exhibit 14: Non-antimicrobial CVCs – Market size & forecast
Exhibit 15: Non-antimicrobial CVCs – Year over year growth
Exhibit 16: Antimicrobial CVCs – Market size & forecast
Exhibit 17: Antimicrobial CVCs – Year over year growth
Exhibit 18: Global CVCs market by product type 2016
Exhibit 19: Segmentation of global CVCs market by product type 2016 (%)
Exhibit 20: Global CVCs market segmentation by design
Exhibit 21: Global CVCs market by end-users 2016
Exhibit 22: Global CVCs market – market size & forecast
Exhibit 23: Regional comparison
Exhibit 24: Global CVCs market segmentation by geography 2016-2021 (%)
Exhibit 25: Global CVCs market segmentation by geography 2016-2021 ($ millions)
Exhibit 26: Global CVCs market analysis by geography
Exhibit 27: Americas – market size & forecast
Exhibit 28: Americas – Year over year growth
Exhibit 29: Top 3 countries in Americas
Exhibit 30: EMEA – market size & forecast
Exhibit 31: EMEA – Year over year growth
Exhibit 32: Top 3 countries in EMEA
Exhibit 33: APAC – market size & forecast
Exhibit 34: APAC – Year over year growth
Exhibit 35: Top 3 countries in APAC
Exhibit 36: Product recalls in global CVCs market 2016-2017
Exhibit 37: Competitive structure analysis of global CVCs market 2016
Exhibit 38: Teleflex: Key highlights
Exhibit 39: Teleflex: Strength assessment
Exhibit 40: Teleflex: Strategy assessment
Exhibit 41: Teleflex: Opportunity assessment
Exhibit 42: B. Braun Melsungen: Key highlights
Exhibit 43: B. Braun Melsungen: Strength assessment
Exhibit 44: B. Braun Melsungen: Strategy assessment
Exhibit 45: B. Braun Melsungen: Opportunity assessment
Exhibit 46: C. R. Bard: Key highlights
Exhibit 47: C. R. Bard: Strength assessment
Exhibit 48: C. R. Bard: Strategy assessment
Exhibit 49: C. R. Bard: Opportunity assessment
Exhibit 50: Vygon: Key highlights
Exhibit 51: Vygon: Strength assessment
Exhibit 52: Vygon: Strategy assessment
Exhibit 53: Vygon: Opportunity assessment
Exhibit 54: Cook: Key highlights
Exhibit 55: Cook: Strength assessment
Exhibit 56: Cook: Strategy assessment
Exhibit 57: Cook: Opportunity assessment
Exhibit 58: Edward Lifesciences: Key highlights
Exhibit 59: Edward Lifesciences: Strength assessment
Exhibit 60: Edward Lifesciences: Strategy assessment
Exhibit 61: Edwards Lifesciences: Opportunity assessment
